1 Min Read
Jan 30 (Reuters) - Mallinckrodt Plc:
* FIRST PATIENT ENROLLED IN MALLINCKRODT PHASE 4 TRIAL OF H.P. ACTHAR® GEL (REPOSITORY CORTICOTROPIN INJECTION) FOR PULMONARY SARCOIDOSIS Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.